In the field of sleep medicine, obtaining accurate and reliable data is paramount for proper diagnosis and treatment. This is the driving force behind Dymedix Diagnostics, a company that has been at the forefront of developing innovative diagnostic sleep sensors and electrodes for clinical sleep studies. Founded in 2001, Dymedix’s […]
Author: SleepWorld Magazine
Bridging Obesity Medicine and Sleep Medicine
Recent research has elevated the management of obesity in patients with sleep disorders to a prominent position in clinical practice. Obesity has been capturing attention across social media, mainstream news, and even in cultural references such as South Park specials and Jimmy Kimmel’s 2023 Oscars commentary. This heightened focus underscores […]
EnsoData Appoints Chief Commercial Officer, Bobby Cockrill, MBA
EnsoData, an innovator in AI solutions in sleep medicine, adds Bobby Cockrill, MBA, as Chief Commercial Officer, (CCO). Cockrill will oversee strategy and execution of sales and marketing functions and continue accelerating EnsoSleep PPG™, EnsoSleep™, RPM, and EnsoTherapy™ adoption across North America. Cockrill comes from Bardy Diagnostics (BDx), where he […]
EnsoData partners with ABM to add Positional Data to EnsoSleep PPG
EnsoData, a leader in healthcare AI technology, is partnering with Advanced Brain Monitoring (ABM) to add position data captured by ABM’s Night Shift sleep positioner into the FDA-cleared EnsoSleep PPG home sleep test (HST). Adding positional data to EnsoSleep PPG offers providers accurate supine AHI severity insights, leading to better […]
Apnimed Announces SynAIRgy Phase 3 Results
Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today announced positive topline results from its pivotal Phase 3 SynAIRgy clinical trial evaluating the efficacy and safety of Apnimed’s lead […]
Takeda Reports Positive NT1 Trial Results for Oveporexton
Takeda announced that the New England Journal of Medicine published data from the Phase 2b trial of oveporexton (TAK-861) in people with narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to restore orexin signaling to address the underlying orexin deficiency that causes NT1. Results demonstrated […]
Beatrice Blanch Receives 2025 A-STEP/STAR Educational Grant
Today, the Board of Registered Polysomnographic Technologists (BRPT) announced the winner of its A-STEP/STAR Educational Grant Program for individuals interested in pursuing a career in sleep technology and/or those who are currently working as sleep technicians who would like to become a registered polysomnographic technologist (RPSGT). Beatrice Blanch, a sleep […]
EnsoData Launches AI-Powered Remote Physiological Monitoring
EnsoData, an innovator in AI healthtech solutions, is proud to introduce a new RPM (remote physiological monitoring) offering to the EnsoSleep PPG ecosystem of AI tools. EnsoData’s RPM solution allows clinicians to seamlessly monitor patients over time and proactively intervene when patients need support with their therapy the most. RPM […]
Panthera Dental Presents New Research at AADSM & SLEEP 2025
Panthera Dental is proud to announce that their abstracts were accepted for poster presentation at the AADSM and for poster and oral presentation at the SLEEP Annual Meetings. The oral presentation is part of a session entitled “Contemporary Management of Sleep Apnea” (O-13). Information regarding the 2025 IIR Grant will […]
Resmed Acquires VirtuOx
Resmed announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. The acquisition reflects Resmed’s commitment to improving the way care is delivered by making it more accessible, coordinated, and patient-friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to […]













